NARAL Pro-Choice America Commends FDA for Putting Women’s Health, Sound Science First

Washington, D.C. – Nancy Keenan, president of NARAL Pro-Choice America, issued the following statement in response to the Food and Drug Administration's (FDA) announcement that it will comply with a federal court ruling calling for the agency to heed scientific findings and allow 17-year-old women to have over-the-counter access to Plan B®, an emergency contraceptive often referred to as the "morning-after" pill.

"The FDA's decision is an important sign that, finally, science will trump politics when it comes to public health," Keenan said. "This decision is in line with sound medical findings and puts women's health first. What a welcome change from the FDA under President Bush where, as the federal court case documented, political shenanigans and gamesmanship trumped good health and sound science, delaying women's access to emergency contraception."

You can learn more about emergency contraception on our website.

Contact:
Ted Miller, 202.973.3032